This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Sudhir Agrawal
President and Founder at Arnay Sciences


Sudhir Agrawal, D. Phil., FRSC, is the founder and President of ARNAY Sciences LLC. He also serves as an Affiliate Professor in the Department of Medicine at UMass Chan Medical School. Over the last three decades, his research has focused on discovering and developing RNA therapeutics, including antisense and immunotherapy. He has published over 300 research papers and is listed as a co-inventor of more than 400 patents worldwide. He has edited four books on oligonucleotides and antisense technology, including a recent book on ‘Advances in Nucleic Acid Therapeutics’ by the Royal Society of Chemistry. He has founded multiple biotech companies. He is currently serving as a member of the scientific advisory board of several biotechnology companies pursuing RNA therapeutics.

Agenda Sessions

  • Chemical Engineering of Oligonucleotides: Applications for RNA Therapeutic